| Literature DB >> 20937527 |
Chunying Shi1, Wei Chen, Yannan Zhao, Bing Chen, Zhifeng Xiao, Zhenliang Wei, Xianglin Hou, Jinglong Tang, Zhaoxu Wang, Jianwu Dai.
Abstract
Biomaterials are increasingly used in the repair of tissue defects. The aim of the present study was to evaluate a new composite biomaterial for reconstruction of a 2 × 2.5 cm full-thickness abdominal wall defect. In this study, the collagen membrane was activated with the engineered human basic fibroblast growth factor (bFGF). To enhance the binding of bFGF to collagen membranes, a specific peptide of collagen-binding domain (CBD) was fused to the N-terminal of bFGF. After implantation, little adhesion was caused in collagen/CBD-bFGF, collagen/NAT-bFGF and collagen/PBS groups. Moreover, collagen/CBD-bFGF group could effectively promote the vascularization at 30 d after surgery and significantly accelerate the integration of myofibers into the collagen material at 90 d after surgery compared to the other two groups. Due to the replacement of the myofibers in materials, the mechanical strength of implanted biomaterials in collagen/CBD-bFGF group was also greater than the other two groups at 90 d after surgery. Thus, the collagen/CBD-bFGF composite biomaterial was promising for the treatment of full-thickness abdominal wall defect.Entities:
Mesh:
Substances:
Year: 2011 PMID: 20937527 DOI: 10.1016/j.biomaterials.2010.09.038
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479